The Risk of Developing Keratinocyte Malignancies in Patients with Cutaneous T-cell Lymphoma

J Invest Dermatol. 2024 Dec 31:S0022-202X(24)03046-X. doi: 10.1016/j.jid.2024.12.009. Online ahead of print.

Authors

Teresa Duong¹, Ramsay Hafer¹, Henry Y Yang¹, Julianna Tolotta¹, Jenna L Mandel¹, Lauren Banner¹, Pierluigi Porcu², Neda Nikbakht³

Affiliations

¹ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA.
² Division of Hematologic Malignancies and Cellular Therapy, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA.
³ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA. Electronic address: [email protected].

PMID: 39746573
DOI: 10.1016/j.jid.2024.12.009

No abstract available

Keywords: Basal Cell Carcinoma; Cutaneous T Cell Lymphoma (CTCL); Epidemiology; Mycosis Fungoides; Squamous Cell Carcinoma.